Cost-Utility Evaluation of Insulin Glargine 300 (GLA-300) Versus Insulin Glargine 100 (GLA-100) in Patients with Type 2 Diabetes Mellitus (T2DM)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1887
https://www.valueinhealthjournal.com/article/S1098-3015(16)33253-3/fulltext
Title :
Cost-Utility Evaluation of Insulin Glargine 300 (GLA-300) Versus Insulin Glargine 100 (GLA-100) in Patients with Type 2 Diabetes Mellitus (T2DM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33253-3&doi=10.1016/j.jval.2016.09.1887
First page :
A675
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1786